https://industryfocusswitzerland.com/article/904694662-mysartorial-unveils-advanced-digital-platform-as-global-demand-for-bespoke-european-footwear-accelerates Industry Focus Switzerland en PressRelease 2026-04-09T22:39:42+00:00 MySartorial Unveils Advanced Digital Platform as Global Demand for Bespoke European Footwear Accelerates https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829323-my-sartorial-logo-1000x1000.png https://industryfocusswitzerland.com/article/904688444-mindit-io-launches-partnership-with-sap-to-promote-data-engineering-and-ai-transformation-through-sap-bdc-in-europe Industry Focus Switzerland en PressRelease 2026-04-09T12:35:01+00:00 mindit.io Launches Partnership with SAP to Promote Data Engineering and AI Transformation through SAP BDC in Europe https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829297-sap-bdc-mindit-io-1440x720.png https://industryfocusswitzerland.com/article/904712808-c4-therapeutics-expands-long-term-partnership-with-roche-through-new-collaboration-agreement-focused-on-discovering-and-developing-degrader-antibody Industry Focus Switzerland en PressRelease 2026-04-09T10:59:00+00:00 C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://industryfocusswitzerland.com/article/904658364-novartis-announces-expansion-of-community-health-programs-to-close-gaps-in-heart-disease-and-cancer-care-targeting-more-than-30-countries-by-2030 Industry Focus Switzerland en PressRelease 2026-04-09T05:15:00+00:00 Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030 https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://industryfocusswitzerland.com/article/904658390-basilea-erh-lt-zus-tzliche-usd-6-mio-von-carb-x-f-r-die-klinische-entwicklung-des-antibiotikums-bal2420 Industry Focus Switzerland en PressRelease 2026-04-09T05:15:00+00:00 Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420 https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://industryfocusswitzerland.com/article/904658595-basilea-awarded-additional-carb-x-funding-of-usd-6-million-to-support-the-clinical-development-of-antibiotic-bal2420 Industry Focus Switzerland en PressRelease 2026-04-09T05:15:00+00:00 Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg